On Demand Replay: 10th Annual Primary Care Winter Conference
|
$585.00
Use promo code (Limited Offer)
20 CREDITS
  Hurry! Offer expires June 30, 2022 at 11:59 pm ET!
|
|
All recorded video lectures from the 10th Annual Primary Care Winter Conference in Maui, Hawaii on March 5-9, 2022Course Content
| DAY 1 – On Demand Replay: SATURDAY, March 5, 2022 | |
| M. Look, MD | Intervention Across the Weight Continuum: The Importance of Recognizing and Addressing Pre-Obesity |
| M. Look, MD | Creating an Individualized Treatment Plan for Patients with Obesity |
| K. Kulasa, MD | How to Integrate SGLT2 Inhibitors and GLP-1 Receptor Agonists into Primary Care |
| K. Kulasa, MD | Insulin and Glucose Monitoring in the Primary Care Setting |
| DAY 2 – On Demand Replay: SUNDAY, March 6, 2022 | |
| J. Basile, MD | Cases in Special Populations with Hypertension |
| J. Basile, MD | Secondary Causes of Hypertension: An Update |
| D. Plourd, MD | Osteoporosis Update |
| D. Plourd, MD | Practical Contraceptive Update |
| DAY 3 – On Demand Replay: MONDAY, March 7, 2022 | |
| S. Nahas, MD | Headache in Primary Care |
| S. Nahas, MD | Managing Migraine: Beyond the Basics |
| D. Brenner, MD | I Don't Understand Why Laxatives are Failing? The Wrong Treatment for the Wrong Disorder |
| D. Brenner, MD | The Nuts and Bolts of IBS: Simplification of Diagnostic Strategies and Implementation of Evidence-Based Treatments |
| DAY 4 – On Demand Replay: TUESDAY, March 8, 2022 | |
| L. VanWagner, MD | Case-based Approach to Abnormal LFTs |
| L. VanWagner, MD | Updates in Non-alcoholic Fatty Liver Disease (NAFLD): A Primer for the PCP |
| J. Basile, MD | Primary Prevention of Cardiovascular Disease: An Update |
| D. Plourd, MD | Hot Topics in Women’s Health |
| DAY 5 – On Demand Replay: WEDNESDAY, March 9, 2022 | |
| R. Usatine, MD | Advances in Skin Cancer Diagnosis and Treatment |
| R. Usatine, MD | Acne and Other Facial Rashes |
| B. Slawski, MD | Key Topics In Preoperative Consultation: Diagnostic Testing, CVD Assessment, VTE & Anticoagulation, Sleep Apnea, Pre-Op Assessment And More! |
Program Overview
Presented by Continuing Education Company (CEC) for the past 30 years, our Primary Care CME Conference Series is designed to update primary care clinicians in rapidly changing therapeutic areas. This CME activity is comprised of recordings from the 10th Annual Essentials in Primary Care Winter Conference that took place in Maui, Hawaii on March 5-9, 2022. The emphasis of this course is on practical and useful information for clinical practice.
This CME program will educate and promote improved patient outcomes in a broad range of therapeutic areas commonly encountered in the primary care practice. This activity will highlight the latest science related to a variety of specialty areas, presented in a practical and patient-focused manner relevant to the primary care setting. The format of this course is streaming-only (video recordings are not downloadable).
Learning Objectives:
As a result of this educational activity, participants should be better able to:
- Assess and provide patients with an accurate diagnosis and optimal care for a broad range of disorders seen in primary care.
- Utilize current guidelines in the diagnosis and management of commonly encountered therapeutic issues.
- Formulate comprehensive evidence-based interventions and treatment strategies that will lead to the reduction of risk factors and improved long-term outcomes.
Post-Test and Evaluation:
After completing the CME activity, you must successfully complete a post-test and fill out a program evaluation form. You will then be able to view and print your CME certificate. Login into CME365 to view your transcript and reprint your certificate at any time.
Faculty
Jan N. Basile, MD, FACP, FASH, FAHA
Professor of Medicine
Division of Cardiology
Medical University of South Carolina
Ralph H Johnson VA Medical Center
Previous Vice-Chair of Clinical Programs AHA Council of Hypertension
US National Leader SURPASS-CVOT
Charleston, SC
Darren M. Brenner, MD
Associate Professor of Medicine and Surgery
Irene D. Pritzker Foundation Research Scholar
Director, Northwestern Neurogastromotility and Integrated Bowel Dysfunction Programs
Director, Motts Tonelli GI Physiology Laboratory
Northwestern University Feinberg School of Medicine
Chicago, IL
Kristen Kulasa, MD
Clinical Professor of Medicine
Chief, Division of Endocrinology, Diabetes and Metabolism
Director, Inpatient Glycemic Control
University of California, San Diego
San Diego, CA
Michelle L. Look, MD, FAAFP
Medical Director of Clinical Research
San Diego Sports Medicine and Family Health Center
Primary Care Specialist
Diplomate, American Board of Obesity Medicine
San Diego, CA
Stephanie J. Nahas, MD, MSEd, FAHS, FAAN
Associate Professor of Neurology
Director, Headache Medicine Followship Program
Assistant Director, Neurology Residency Program
Thomas Jefferson University Hospitals
Philadelphia, PA
David M. Plourd, MD, FACOG
Staff Obstetrician & Gynecologist & Obstetric Hospitalist
Formerly Naval Hospital
San Diego, CA
Barbara A. Slawski, MD, MS, SFHM
Professor of Medicine and Orthopaedic Surgery
Chief, Section of Hospital Medicine
Division of General Internal Medicine
Medical College of Wisconsin
Milwaukee, WI
Richard P. Usatine, MD
Professor of Family and Community Medicine
Professor of Dermatology and Cutaneous Surgery
University of Texas Health San Antonio
Medical Director, University Health System Skin Clinic
San Antonio, TX
Lisa B VanWagner, MD, MSc, FAST, FAHA
Assistant Professor of Medicine and Preventive Medicine
Division of Gastroenterology & Hepatology and Epidemiology
Northwestern University Feinberg School of Medicine
Chicago, IL
Accreditation
American Academy of Family Physicians: The AAFP has reviewed On Demand Replay: 10th Annual Primary Care Winter Conference (Enduring) and deemed it acceptable for up to 20 Enduring Materials, Self-Study AAFP Prescribed credits. Term of Approval is from 3/28/2022 to 3/1/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA PRA Category 1 Credits™: Continuing Education Company, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education Company designates this enduring material for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 20 hours of Category 1 credit for completing this activity.
AANPCB: The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Nurse Practitioners may receive a maximum of 20 hours of participation, 12 of which can be used towards Pharmacology, for completing this activity.
Release Date: 4/3/2022
Expiration Date: 3/1/2023 (Date after which this enduring material is no longer certified for credit.)
Medium: Internet/Enduring Material, Video/Audio
Faculty/Planning Committee Disclosures
Review and Planning Committee Disclosures:
The following individuals have indicated that they have no relevant financial relationships with a ineligible company that may impact upon this CME activity:
- Raymond E. Major – Reviewer
- Walter Ejnes, CHCP - Reviewer & Planning Committee (Continuing Education Company)
- Beth Townsend - Reviewer (Continuing Education Company)
- Su Barnwell - Planning Committee (Continuing Education Company)
Faculty Disclosures:
The following individuals were responsible for developing their own content, which has been reviewed by Continuing Education Company’s Medical Education Advisory Committee to ensure it is unbiased. Additionally, all individuals have indicated that if they had a financial relationship(s) with an ineligible company over the past 24 months, this relationship has been mitigated and does not have an impact upon this CME activity. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
| Faculty | Disclosures |
| Jan Basile, MD | Consultant: Eli Lilly (SURPASS); Medtronic Adjudication Committee (AF-Hypertension Renal Denervation Study); Up-to-Date (Hypertension Section) |
| Research Grant: Ablative Solutions (Target BP 1); ReCor (RADIANCE I and II) | |
| Darren M. Brenner, MD | Advisory Board: Allergan Pharmaceuticals; Arena Pharmaceuticals; Ironwood; Salix Pharmaceuticals; Takeda Pharmaceuticals |
| Consultant: Alfasigma Pharmaceuticals; Allergan Pharmaceuticals; Alnylam Pharmaceuticals; Arena Pharmaceuticals; Ironwood; Redhill Biopharma; Salix Pharmaceuticals; Takeda Pharmaceuticals | |
| Speakers Bureau: Alfasigma Pharmaceuticals; Allergan Pharmaceuticals; Ironwood; Redhill Biopharma; Salix Pharmaceuticals; Takeda Pharmaceuticals | |
| Kristen Kulasa, MD | Nothing to Disclose |
| Michelle L. Look, MD | Advisory Board: Boehringer Ingelheim; Gelesis |
| Consultant: Gelesis | |
| Stephanie J. Nahas, MD | Author/Editor: Massachusetts Medical Society; Springer; Wolters-Kluwer |
| Consultant: Alder Lundbeck; Allergan/Abbvie; Amgen Novartis; Axsome; BioDelivery Sciences; Biohaven; Ely Lilly; Fenix Group International; Impel; Nesos Corp (formerly Vorso Corp); Teva | |
| Research Grant: Teva | |
| Speakers Bureau: Allergan/Abbvie; Amgen Novartis; Ely Lilly; Teva | |
| David M. Plourd, MD | Nothing to Disclose |
| Barbara A. Slawski, MD | Nothing to Disclose |
| Richard P. Usatine, MD | Nothing to Disclose |
| Lisa B. VanWagner, MD | Grant Recipient: AMRA; Digestive Health Foundation; Intercept Pharmaceuticals; NHLBI; NIDDK; W.L. Gore & Associates |
Unlabeled Use Declaration:
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
Statement of Disclosure and Independence:
It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Conflict of Interest (COI) and Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any relevant financial interest or other relationships which they or their spouse/partner have with (a) with the manufacturer(s) of any commercial products(s) and/or provider(s) of commercial services discussed in an educational presentation and (b) with any commercial supporters of the activity. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All potential conflicts of interest have been identified and resolved, and are listed above.
The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.
Computer Requirements
Flash Player 10 or later, and one of the following browsers:
- Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
- Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
- Linux: Firefox 1.x and later
HTML5 via one of the following browsers:
- Windows: Google Chrome (latest version)
- Mac: Safari 6.0.5 or later, Google Chrome (latest version)
- Mobile: Safari in Apple iOS 6 or later
30 Day Money Back Guarantee
CEC stands behind our product. If you are not satisfied with your online course for any reason, send a written cancellation request and reason to registration@cmemeeting.org within 30 days of the purchase date for a full refund. (Cancellations on CME365™ Collection Series will incur a 5% processing fee.) Please note you may watch any of the content but once you claim credit for any online course, no refund can be granted.